Literature DB >> 28126382

Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.

Kelby W Wegner1, Danish Saleh2, Alexei Degterev3.   

Abstract

A process of regulated necrosis, termed necroptosis, has been recognized as a major contributor to cell death and inflammation occurring under a wide range of pathologic settings. The core event in necroptosis is the formation of the detergent-insoluble 'necrosome' complex of homologous Ser/Thr kinases, receptor protein interacting kinase 1 (RIPK1) and receptor interacting protein kinase 3 (RIPK3), which promotes phosphorylation of a key prodeath effector, mixed lineage kinase domain-like (MLKL), by RIPK3. Core necroptosis mediators are under multiple controls, which have been a subject of intense investigation. Additional, non-necroptotic functions of these factors, primarily in controlling apoptosis and inflammatory responses, have also begun to emerge. This review will provide an overview of the current understanding of the human disease relevance of this pathway, and potential therapeutic strategies, targeting necroptosis mediators in various pathologies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28126382      PMCID: PMC5325808          DOI: 10.1016/j.tips.2016.12.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  180 in total

1.  RIPK1- and RIPK3-induced cell death mode is determined by target availability.

Authors:  W D Cook; D M Moujalled; T J Ralph; P Lock; S N Young; J M Murphy; D L Vaux
Journal:  Cell Death Differ       Date:  2014-06-06       Impact factor: 15.828

2.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

3.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

4.  The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.

Authors:  Gabriela Brumatti; Chunyan Ma; Najoua Lalaoui; Nhu-Y Nguyen; Mario Navarro; Maria C Tanzer; Jennifer Richmond; Margherita Ghisi; Jessica M Salmon; Natasha Silke; Giovanna Pomilio; Stefan P Glaser; Elisha de Valle; Raffi Gugasyan; Mark A Gurthridge; Stephen M Condon; Ricky W Johnstone; Richard Lock; Guy Salvesen; Andrew Wei; David L Vaux; Paul G Ekert; John Silke
Journal:  Sci Transl Med       Date:  2016-05-18       Impact factor: 17.956

5.  RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.

Authors:  Yasushi Ito; Dimitry Ofengeim; Ayaz Najafov; Sudeshna Das; Shahram Saberi; Ying Li; Junichi Hitomi; Hong Zhu; Hongbo Chen; Lior Mayo; Jiefei Geng; Palak Amin; Judy Park DeWitt; Adnan Kasim Mookhtiar; Marcus Florez; Amanda Tomie Ouchida; Jian-bing Fan; Manolis Pasparakis; Michelle A Kelliher; John Ravits; Junying Yuan
Journal:  Science       Date:  2016-08-05       Impact factor: 47.728

6.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

7.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition.

Authors:  William J Kaiser; Lisa P Daley-Bauer; Roshan J Thapa; Pratyusha Mandal; Scott B Berger; Chunzi Huang; Aarthi Sundararajan; Hongyan Guo; Linda Roback; Samuel H Speck; John Bertin; Peter J Gough; Siddharth Balachandran; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

8.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

9.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

View more
  46 in total

1.  RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer's disease.

Authors:  David C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

2.  Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites.

Authors:  Dan E McNamara; Cole M Dovey; Andrew T Hale; Giovanni Quarato; Christy R Grace; Cristina D Guibao; Jonathan Diep; Amanda Nourse; Casey R Cai; Hong Wu; Ravi C Kalathur; Douglas R Green; John D York; Jan E Carette; Tudor Moldoveanu
Journal:  Cell Chem Biol       Date:  2019-04-25       Impact factor: 8.116

3.  Frontline Science: Staphylococcus aureus promotes receptor-interacting protein kinase 3- and protease-dependent production of IL-1β in human neutrophils.

Authors:  Silvie Kremserova; William M Nauseef
Journal:  J Leukoc Biol       Date:  2018-12-13       Impact factor: 4.962

4.  The Alleviative Effects of Quercetin on Cadmium-Induced Necroptosis via Inhibition ROS/iNOS/NF-κB Pathway in the Chicken Brain.

Authors:  Lili Liu; Yuan Liu; Xi Cheng; Xinyuan Qiao
Journal:  Biol Trace Elem Res       Date:  2021-01-04       Impact factor: 3.738

Review 5.  Programming inflammatory cell death for therapy.

Authors:  Shelbi Christgen; Rebecca E Tweedell; Thirumala-Devi Kanneganti
Journal:  Pharmacol Ther       Date:  2021-10-04       Impact factor: 12.310

6.  Circulating RIPK3 levels are associated with mortality and organ failure during critical illness.

Authors:  Kevin C Ma; Edward J Schenck; Ilias I Siempos; Suzanne M Cloonan; Eli J Finkelsztein; Maria A Pabon; Clara Oromendia; Karla V Ballman; Rebecca M Baron; Laura E Fredenburgh; Angelica Higuera; Jin Young Lee; Chi Ryang Chung; Kyeongman Jeon; Jeong Hoon Yang; Judie A Howrylak; Jin-Won Huh; Gee Young Suh; Augustine Mk Choi
Journal:  JCI Insight       Date:  2018-07-12

7.  Necroptotic astrocytes contribute to maintaining stemness of disseminated medulloblastoma through CCL2 secretion.

Authors:  Hailong Liu; Youliang Sun; Jenny A O'Brien; Janusz Franco-Barraza; Xueling Qi; Hongyu Yuan; Wei Jin; Junping Zhang; Chunyu Gu; Zhenyu Zhao; Chunjiang Yu; Shiyu Feng; Xinguang Yu
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

8.  RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer.

Authors:  Wei Wang; Jill M Marinis; Allison M Beal; Shivraj Savadkar; Yue Wu; Mohammed Khan; Pardeep S Taunk; Nan Wu; Wenyu Su; Jingjing Wu; Aarif Ahsan; Emma Kurz; Ting Chen; Inedouye Yaboh; Fei Li; Johana Gutierrez; Brian Diskin; Mautin Hundeyin; Michael Reilly; John D Lich; Philip A Harris; Mukesh K Mahajan; James H Thorpe; Pamela Nassau; Julie E Mosley; Joshua Leinwand; Juan A Kochen Rossi; Ankita Mishra; Berk Aykut; Michael Glacken; Atsuo Ochi; Narendra Verma; Jacqueline I Kim; Varshini Vasudevaraja; Dennis Adeegbe; Christina Almonte; Ece Bagdatlioglu; Deirdre J Cohen; Kwok-Kin Wong; John Bertin; George Miller
Journal:  Cancer Cell       Date:  2018-11-12       Impact factor: 31.743

Review 9.  RIPK protein kinase family: Atypical lives of typical kinases.

Authors:  Gregory D Cuny; Alexei Degterev
Journal:  Semin Cell Dev Biol       Date:  2020-07-27       Impact factor: 7.727

10.  Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  mSystems       Date:  2021-06-29       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.